| scholarly article | Q13442814 |
| P50 | author | Hermann Einsele | Q1610986 |
| Juergen Loeffler | Q88652700 | ||
| P2093 | author name string | Lutz Uharek | |
| Helmut Ostermann | |||
| Anke Franzke | |||
| Christoph Mueller-Loebnitz | |||
| Max Topp | |||
| P2860 | cites work | A homozygous CARD9 mutation in a family with susceptibility to fungal infections | Q24658090 |
| Surface hydrophobin prevents immune recognition of airborne fungal spores | Q28256741 | ||
| How do microbes evade neutrophil killing? | Q28260721 | ||
| Neutrophils and immunity: challenges and opportunities | Q29617616 | ||
| Early NK cell-derived IFN-{gamma} is essential to host defense in neutropenic invasive aspergillosis | Q30433397 | ||
| T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis | Q30448838 | ||
| Killing of Aspergillus fumigatus by alveolar macrophages is mediated by reactive oxidant intermediates | Q35011464 | ||
| Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling | Q36121769 | ||
| The impact of donor natural killer cell alloreactivity on allogeneic hematopoietic transplantation | Q36176631 | ||
| The Aspergillus fumigatus transcriptional regulator AfYap1 represents the major regulator for defense against reactive oxygen intermediates but is dispensable for pathogenicity in an intranasal mouse infection model | Q36313729 | ||
| The influence of high-efficiency particulate air filtration on mortality and fungal infection among highly immunosuppressed patients: a systematic review | Q36451064 | ||
| Killing of Aspergillus spores depends on the anatomical source of the macrophage | Q37100918 | ||
| Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation | Q37130676 | ||
| Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/ | Q37164067 | ||
| Restoration of NET formation by gene therapy in CGD controls aspergillosis | Q37372812 | ||
| Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation | Q37381313 | ||
| Activity of voriconazole combined with neutrophils or monocytes against Aspergillus fumigatus: effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. | Q39558748 | ||
| Epidemiology of sepsis in Germany: results from a national prospective multicenter study | Q40239427 | ||
| Generation of Th1 T cell responses directed to a HLA Class II restricted epitope from the Aspergillus f16 allergen. | Q40470166 | ||
| Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation | Q41978755 | ||
| Factor H and factor H-related protein 1 bind to human neutrophils via complement receptor 3, mediate attachment to Candida albicans, and enhance neutrophil antimicrobial activity. | Q43222930 | ||
| Index to predict invasive mold infection in high-risk neutropenic patients based on the area over the neutrophil curve | Q43844949 | ||
| In vivo GM-CSF prevents dexamethasone suppression of killing of Aspergillus fumigatus conidia by bronchoalveolar macrophages. | Q43904136 | ||
| Factors associated with overall and attributable mortality in invasive aspergillosis | Q44431234 | ||
| A prospective, randomised study on the use of well-fitting masks for prevention of invasive aspergillosis in high-risk patients. | Q46006886 | ||
| Fungal infections after haematology unit renovation: evidence of clinical, environmental and economical impact | Q46808698 | ||
| Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants. | Q53949766 | ||
| Proinflammatory response of immature human dendritic cells is mediated by dectin-1 after exposure to Aspergillus fumigatus germ tubes. | Q54546379 | ||
| TLR1 and TLR6 Polymorphisms Are Associated with Susceptibility to Invasive Aspergillosis after Allogeneic Stem Cell Transplantation | Q57908265 | ||
| B7/CD28-Dependent CD4+CD25+ Regulatory T Cells Are Essential Components of the Memory-Protective Immunity to Candida albicans | Q58855396 | ||
| Dendritic Cells Transport Conidia and Hyphae of Aspergillus fumigatus from the Airways to the Draining Lymph Nodes and Initiate Disparate Th Responses to the Fungus | Q58855400 | ||
| Induction of ERK-kinase signalling triggers morphotype-specific killing of Candida albicans filaments by human neutrophils | Q61441049 | ||
| Purified recombinant A. fumigatus allergens induce different responses in mice | Q61499478 | ||
| Generation of highly purified and functionally active human TH1 cells against Aspergillus fumigatus | Q63386804 | ||
| IL-10 exerts suppressive and enhancing effects on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus | Q71929945 | ||
| Antifungal activity of elutriated human monocytes against Aspergillus fumigatus hyphae: enhancement by granulocyte-macrophage colony-stimulating factor and interferon-gamma | Q72727765 | ||
| Elevated serum concentrations of interleukin-10 in nonneutropenic patients with invasive aspergillosis | Q73335200 | ||
| Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey | Q80052810 | ||
| Invasive aspergillosis in critically ill patients without malignancy | Q80269940 | ||
| Routine sampling of air for fungi does not predict risk of invasive aspergillosis in immunocompromised patients | Q80564176 | ||
| Protective role of interleukin-10 promoter gene polymorphism in the pathogenesis of invasive pulmonary aspergillosis after allogeneic stem cell transplantation | Q81398889 | ||
| Interaction analyses of human monocytes co-cultured with different forms of Aspergillus fumigatus | Q82926462 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | immunology | Q101929 |
| P304 | page(s) | 102934 | |
| P577 | publication date | 2013-01-21 | |
| P1433 | published in | Interdisciplinary Perspectives on Infectious Diseases | Q26842016 |
| P1476 | title | Immunological aspects of Candida and Aspergillus systemic fungal infections | |
| P478 | volume | 2013 |
| Q89955684 | Candida bloodstream infection in patients with systemic autoimmune diseases |
| Q26776056 | New insights on the development of fungal vaccines: from immunity to recent challenges |
| Q26774692 | Optimizing Outcomes in Immunocompromised Hosts: Understanding the Role of Immunotherapy in Invasive Fungal Diseases |
| Q38153458 | The Eagle-like effect of echinocandins: what's in a name? |
Search more.